<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
MEdia Clips

CU Anschutz In The News

National Public Radio

Boosting Vaccination Rates, One Conversation At A Time

news outletNational Public Radio
Publish DateJanuary 26, 2018

Dr. Amanda Dempsey, associate professor of pediatrics at the University of Colorado School of Medicine, talks about why some people are hesitant to get their children vaccinated.

Full Story

The high cost of Vivitrol makes it inaccessible to many who need it

news outlet9News
Publish DateJanuary 25, 2018

Dr. Rob Valuck, a professor at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences, discussed the high price of a drug used to fight opioid addiction.

Full Story
The Denver Post

To combat addiction, several Colorado hospitals tried a new approach to treating pain. Their use of opioids plummeted

news outletThe Denver Post
Publish DateJanuary 25, 2018

Dr. Heidi Wald, a professor at the University of Colorado School of Medicine who helped run the study, said the results come with caveats. The project didn’t have a control group, so it did not measure whether opioid use also dipped at hospitals that did not participate in the program. The results presented Thursday also did not include measurements of patient satisfaction, which would reveal whether the alternatives controlled pain as well as opioids.

Full Story

Transportation incidents cited as leading cause for uptick in work-related deaths in Colorado

news outletDenverite
Publish DateJanuary 22, 2018

Colorado had the 39th lowest fatal injury rate per 100,000 full-time workers out of all 50 states, according to BLS. The director of the Center for Health, Work & Environment in Aurora, Dr. Lee Newman, said we could still do better. “One preventable workplace fatality is one preventable workplace fatality too many,” Newman said. “As a doctor, I can tell you I’ve seen enough suffering among workers who get injured on the job to say we should be aiming for zero.”

Full Story

Cannabis Could Be The Most Profitable Ingredient In Skincare, If The U.S. Government Allows It

news outletForbes
Publish DateJanuary 16, 2018

Robert Dellavalle, M.D., Ph.D., MSPH, Professor of Dermatology and Public Health at the University of Colorado School of Medicine and the Colorado School of Public Health was one of the authors of an April 2017 Journal of the American Academy Dermatology paper, a survey of all the literature on the potential for cannabinoids on humans and animals titled “The role of cannabinoids in dermatology.” Devalle and his peers have taken a similar approach to Capobianco. “We don’t have rigorous studies so we’ve started a registry of patients to see what they are using and if they think its working .”

Full Story

Loveland family raises money for cancer research with rescue cat

news outletReporter-Herald
Publish DateJanuary 14, 2018

Reagan chose Lung Cancer Colorado Fund to give to because both Ron and Dorothy saw doctors at Anschutz Medical Campus, and administrative fees are not taken out so more goes to research. The family also knows that whatever advancements are made from this research could help other forms of cancer.

Full Story
CBS4 Denver

Pharmacy Students Help Provide Free Flu Shots At Stock Show

news outletCBS4 Denver
Publish DateJanuary 13, 2018

“It’s been a tough flu year so we wanted to make sure that the vaccine was available. So, when the university reached out to King Soopers, we were able to donate 150 vaccines to provide to anyone who hasn’t been vaccinated yet to try and get some additional coverage and protection for those folks,” said Morgan.

Full Story
Pittsburgh Post-Gazette

Cuba has a lung cancer vaccine, but many American patients can’t get it without breaking the law

news outletPittsburgh Post-Gazette
Publish DateJanuary 10, 2018

… others complain that the vaccine has been oversold and is in sore need of further study. Dr. Robert Doebele, associate professor of medical oncology at the University of Colorado Denver and a senior editor of the American Association for Cancer Research’s journal Clinical Cancer Research, recalls sitting in a meeting with a dozen other oncologists discussing the best way to market a drug. Someone in the room called out, “Do whatever Cimavax does!”

Full Story